PUBLICACIONES
En esta sección encontrarás una selección de las publicaciones científicas del Dr. Pedro Recabal, cirujano urólogo oncólogo especializado en el tratamiento del cáncer urológico. Sus investigaciones están enfocadas en mejorar el diagnóstico, tratamiento y calidad de vida de los pacientes con cáncer de próstata, riñón, vejiga, testículo y vía urinaria.
Los estudios aquí presentados reflejan un compromiso con la medicina basada en evidencia, la innovación quirúrgica —incluyendo cirugía robótica— y la búsqueda constante de mejores resultados clínicos.
Estas publicaciones están dirigidas tanto a profesionales de la salud como a pacientes interesados en conocer más sobre los avances en urología oncológica.
Capítulos en Libros
1
Recabal P, Laudone V.P. Developing a Robotic Surgery Program. In: Fong Y., Woo Y., Hyung W., Lau C., Strong V. (eds) The SAGES Atlas of Robotic Surgery pp.29-36. Springer, Cham (2018)
2
Recabal P, Lee CH, Rathkopf D. Chapter: Prostate Cancer in Eldery Patients. In Handbook of Geriatric Oncology, Korc-Grodzicki and Tew. Demos Medical, Springer Publishing Group 2017
3
Castillo S, Navarrete MF, Recabal P. Genética de la Hipertensión Arterial. In: Andonie C, Zehnder C, eds. Hipertensión Arterial. Santiago: Mediterráneo Limitada. 2008: 21-35.
Artículos en Revistas Científicas
1
Gold SA, Pere MM, Assel M, Doudt AD, Durdin TD, Silagy AW, Dean LW, Recabal P, et al.
Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical Trial.
JAMA Surg. 2025 Aug 1;160(8):875-883. doi: 10.1001/jamasurg.2025.1987.PMID: 40601345
2
STARSurg Collaborative. Among authors: Recabal P.
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Lancet Digit Health. 2024 Jul;6(7):e507-e519. doi: 10.1016/S2589-7500(24)00065-7.
3
González-Browne C, Díaz J, Pinto I, Recabal P, Sandoval C, Vidal A, Altamirano-Villarroel J.
Cytoreductive radical prostatectomy versus no local treatment in patients with metastatic prostate cáncer.
Medwave. 2023 May 25;23(4). doi: 10.5867/medwave.2023.04.2661.
4
GlobalSurg Collaborative. Among authors: Recabal P.
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
Anaesthesia. 2022 Jan;77(1):28-39. doi: 10.1111/anae.15563.
5
COVIDSurg Collaborative; GlobalSurg Collaborative. Among authors: Recabal P.
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.
Anaesthesia. 2021 Mar 9. doi: 10.1111/anae.15458.
6
COVIDSurg Collaborative; GlobalSurg Collaborative. Among authors: Recabal P.
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
Br J. Surg. 2021 Mar 24. doi: 10.1093/bjs/znab101.
7
Rosenzweig B, Corradi RB, Budhu S, Alvim R, Recabal P, La Rosa S, et al.
Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer.
Sci Rep. 2021 Mar 1;11(1):4842.
8
Recabal P, Lee T, Vertosick E, Manasia M, Eastham J, Touijer K, et al.
Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy.
World J. Urol. 2020 Apr;38(4):965–970.
9
Recabal P, Rosenzweig B, Bazzi WM, Carver BS, Sheinfeld J.
Malignant Mesothelioma of the Tunica Vaginalis Testis: Outcomes Following Surgical Management Beyond Radical Orchiectomy.
Urology. 2017 Sep;107:166–170.
10
Lee DJ, Recabal P, Sjoberg DD, Thong A, Lee JK, Eastham JA, et al.
Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: A Prospective Study.
J Urol. 2016 Sep;196(3):697–702.
11
Recabal P, Assel M, Sjoberg DD, Lee D, Laudone VP, Touijer K, et al.
The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
J Urol. 2016 Aug;196(2):374–381.
12
Recabal P, Assel M, Musser JE, Caras RJ, Sjoberg DD, Coleman JA, et al.
Erectile Function Recovery after Radical Prostatectomy in Men with High Risk Features.
J Urol. 2016 Aug;196(2):507–513.
13
Recabal P, Ehdaie B.
The role of MRI in active surveillance for men with localized prostate cancer.
Curr Opin Urol. 2015 Nov;25(6):504–509.
14
Ehdaie B, Poon BY, Sjoberg DD, Recabal P, Laudone V, Touijer K, et al.
Variation of Serum Prostate-Specific Antigen in Men with Prostate Cancer Managed with Active Surveillance.
BJU Int. 2015 Sep 19. doi: 10.1111/bju.13328.
15
Mercado A, Fernández MI, Recabal P, Fleck D, Ledezma R, et al.
Immediate postoperative morbidity in patients with indwelling double-J stent versus overnight-externalized ureteral catheter after tubeless percutaneous nephrolithotomy: a prospective, randomized study.
Urolithiasis. 2013 Jun;41(3):253–256.
16
Rosman BM, Passerotti CC, Kohn D, Recabal P, Retik AB, Nguyen HT.
Hydronephrosis following ureteral reimplantation: When is it concerning?
J Pediatr Urol. 2011 Nov 23.
17
Ossandón E, Recabal P, Acevedo C, Flores JM, Marchant F.
The Lithotripsy Table Height: A Novel Predictor of Outcome in SWL.
Int Braz J Urol. 2011 May–Jun;37(3):355–361.
18
Marchant F, Recabal P, Fernández MI, Osorio F, Benavides.
Postoperative morbidity of tubeless versus conventional percutaneous nephrolithotomy: a prospective comparative study.
J Urol Res. 2011 Feb 20.
19
Passerotti CC, Kalish LA, Chow J, Passerotti AM, Recabal P, et al.
The predictive value of the first postnatal ultrasound in children with antenatal hydronephrosis.
J Pediatr Urol. 2011 Apr;7(2):128–136.
20
Silva A, Rodig N, Passerotti CP, Recabal P, Borer JG, Retik AB, et al.
Risk factors for urinary tract infection after renal transplantation and its impact on graft function in children and young adults.
J Urol. 2010 Oct;184(4):1462–1467.
21
Rodríguez-Navarro AJ, Lagos M, Figueroa C, García C, Recabal P, et al.
Potentiation of local anesthetic activity of neosaxitoxin with bupivacaine or epinephrine: development of a long-acting pain blocker.
Neurotox Res. 2009 Nov;16(4):408–415.
22
Ossandón E, Storme O, Ledesma R, Marchant F, Palma C, Recabal P.
Metabolic study results of 54 patients with high risk of recurrent urolithiasis.
Actas Urol Esp. 2009 Apr;33(4):429–432
23
Pardo RA, Lay-Son G, Aranda W, Dib M, Espina P, Muñoz MJ, et al.
Awareness of post partum women on the effects of folic acid in the prevention of congenital anomalies.
Rev Med Chile. 2007;135(12):1551–1557.
24
Pardo R, Lay-Son G, Aranda W, Recabal P, Navarrete M, Tenhamm T, et al.
Chilean primary health workers' knowledge about folic acid supplementation for the prevention of neural tube defects.
Am J Med Genet A. 2006 Jun 1;140(11):1238–1240.